Erythropoietin priming improves the vasculogenic potential of G-CSF mobilized human peripheral blood mononuclear cells

Cardiovascular Research

Volumn 104, Issue 1, 2014, Pages 171-182

  Kang, Jeehoon ^a,b,c   Yun, Ji Yeon ^b,c   Hur, Jin ^a,b   Kang, Jin A ^b,c   Choi, Jae Il ^b,c   Bum Ko, Seung ^b,c   Lee, Jaewon ^a,b   Kim, Ju Young ^a,b   Hwang, In Chang ^a,c   Park, Young Bae ^a   Kim, Hyo Soo ^a,b,c  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Erythropoietin; G CSF mobilized peripheral blood mononuclear cells; Myocardial infarction; Priming; Vasculogenesis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BETA1 INTEGRIN; CD18 ANTIGEN; CD51 ANTIGEN; ERYTHROPOIETIN; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; INTEGRIN; INTERLEUKIN 10; INTERLEUKIN 8; JANUS KINASE 2; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; ANGIOGENIC PROTEIN; CELL ADHESION MOLECULE; CULTURE MEDIUM; CYTOKINE; JAK2 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL VIABILITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEART INFARCTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; ANIMAL; BLOOD; BONE MARROW CELL; CASE CONTROL STUDY; CELL CULTURE; CULTURE MEDIUM; DISEASE MODEL; DRUG EFFECTS; HINDLIMB; ISCHEMIA; MALE; METABOLISM; MONONUCLEAR CELL; MYOCARDIAL INFARCTION; NUDE MOUSE; PATHOPHYSIOLOGY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROCEDURES; REGENERATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STEM CELL MOBILIZATION; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; TRANSPLANTATION; VASCULARIZATION;

ANGIOGENIC PROTEINS; ANIMALS; BONE MARROW CELLS; CASE-CONTROL STUDIES; CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; CORONARY ARTERY DISEASE; CULTURE MEDIA, CONDITIONED; CYTOKINES; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HINDLIMB; HUMANS; INJECTIONS, SUBCUTANEOUS; ISCHEMIA; JANUS KINASE 2; LEUKOCYTES, MONONUCLEAR; MALE; MICE, NUDE; MUSCLE, SKELETAL; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-AKT; RECOMBINANT PROTEINS; REGENERATION; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84913591330     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu180     Document Type: Article

References (31)

1. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-1918
2. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J, Vanderheyden M, Kim HS, Kang HJ, Strauer BE, VetrovecGW. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a EPO-priming of mobilized PBMCs 181 collaborative systematic review and meta-Analysis of controlled clinical trials. J Am Coll Cardiol 2007;50:1761-1767
3. Delewi R, Andriessen A, Tijssen JG, Zijlstra F, Piek JJ, Hirsch A. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-Analysis of randomised controlled clinical trials. Heart 2013;99:225-232
4. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B. Adult bone marrow cell therapy improves survival and induces long-Term improvement in cardiac parameters: a systematic review and meta-Analysis. Circulation 2012;126:551-568
5. Avraamides CJ, Garmy-Susini B, Varner JA. Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 2008;8:604-617
6. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK, Kim YJ, Soo Lee D, Sohn DW, Han KS, Oh BH, Lee MM, Park YB. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751-756
7. Kang HJ, Yoon EJ, Lee EJ, Kim MK, Suh JW, Park KW, Lee HY, Park KU, Cho YS, Koo BK, Chae IH, Choi DJ, Han KS, Kim HS, Park YB. Cotreatment with darbepoetin and granulocyte colony-stimulating factor is efficient to recruit proangiogenic cell populations in patients with acute myocardial infarction. Cell Transplant 2012;21:1055-1061
8. Kang HJ, Kim MK, Lee HY, Park KW, Lee W, Cho YS, Koo BK, Choi DJ, Park YB, Kim HS. Five-year results of intracoronary infusion of the mobilized peripheral blood stem cells by granulocyte colony-stimulating factor in patients with myocardial infarction. Eur Heart J 2012;33:3062-3069
9. Kang HJ, Kim HS, Koo BK, Kim YJ, Lee D, Sohn DW, Oh BH, Park YB. Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial. Am Heart J 2007; 153:237 e231-238
10. Kang HJ, Lee HY, Na SH, Chang SA, Park KW, Kim HK, Kim SY, Chang HJ, Lee W, Kang WJ, Koo BK, Kim YJ, Lee DS, Sohn DW, Han KS, Oh BH, Park YB, Kim HS. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 2006;114:I145-I151
11. Sato T, Maekawa T, Watanabe S, Tsuji K, Nakahata T. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin. J Clin Invest 2000;106:263-270
12. Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N, Noguchi CT. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 1994; 91:3974-3978
13. Lisowska KA, Debska-Slizien A, Bryl E, Rutkowski B, Witkowski JM. Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment. Artif Organs 2010; 34:654-662
14. Joshi D, Tsui J, Yu R, Shiwen X, Selvakumar S, Abraham DJ, Baker DM. Potential of novel EPO derivatives in limb ischemia. Cardiol Res Pract 2012;2012:213785
15. Westenbrink BD, Lipsic E, van Der Meer P, van Der Harst P, Oeseburg H, Du Marchie Sarvaas GJ, Koster J, Voors AA, van Veldhuisen DJ, van Gilst WH, Schoemaker RG. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J 2007;28: 2018-2027
16. George J, Goldstein E, Abashidze A, Wexler D, Hamed S, Shmilovich H, Deutsch V, Miller H, Keren G, Roth A. Erythropoietin promotes endothelial progenitor cell proliferative and adhesive properties in a PI 3-kinase-dependent manner. Cardiovasc Res 2005; 68:299-306
17. Burger D, Xenocostas A, Feng QP. Molecular basis of cardioprotection by erythropoietin. Curr Mol Pharmacol 2009;2:56-69
18. Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 2008;8:618-631
19. Bischoff J. Cell adhesion and angiogenesis. J Clin Invest 1997;100:S37-S39
20. Kim MS, Lee CS, Hur J, Cho HJ, Jun SI, Kim TY, Lee SW, Suh JW, Park KW, Lee HY, Kang HJ, Lee DS, Koh GY, Nakagami H, Morishita R, Park YB, Kim HS. Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel Tie2/Ets-1 pathway. Circulation 2009;120:2240-2250
21. Taniguchi N, Nakamura T, Sawada T, Matsubara K, Furukawa K, Hadase M, Nakahara Y, MatsubaraH. Erythropoietin prevention trial of coronary restenosis and cardiac remodeling after ST-elevated acute myocardial infarction (EPOC-AMI): a pilot, randomized, placebo-controlled study. Circ J 2010;74:2365-2371
22. Kagaya Y, Asaumi Y, Wang W, Takeda M, Nakano M, Satoh K, Fukumoto Y, Shimokawa H. Current perspectives on protective roles of erythropoietin in cardiovascular system: erythropoietin receptor as a novel therapeutic target. Tohoku J Exp Med 2012;227: 83-91
23. Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, DellEra P, Nico B, Roncali L, Dammacco F. Human erythropoietin induces a pro-Angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999;93:2627-2636
24. Bennis Y, Sarlon-Bartoli G, Guillet B, Lucas L, Pellegrini L, Velly L, Blot-Chabaud M, Dignat-Georges F, Sabatier F, Pisano P. Priming of late endothelial progenitor cells with erythropoietin before transplantation requires the CD131 receptor subunit and enhances their angiogenic potential. J Thromb Haemost 2012;10:1914-1928
25. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, Kim TY, Cho HJ, Kang HJ, Chae IH, Yang HK, Oh BH, Park YB, Kim HS. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and lateoutgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005;112:1618-1627
26. Leeper NJ, Hunter AL, Cooke JP. Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. Circulation 2010;122:517-526
27. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. JAMA 2005; 293:90-95
28. Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003;170:3369-3376
29. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004;24:288-293
30. Dace DS, Khan AA, Kelly J, Apte RS. Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. PLoS One 2008;3: e3381
31. Ho VW, Sly LM. Derivation and characterization of murine alternatively activated (M2) macrophages. Methods Mol Biol 2009;531:173-185